Navigation Links
First aid after tick bites
Date:12/19/2011

This press release is available in German.

For years, Mrs. S. suffered from joint pain and headaches. After an odyssey through doctors' waiting rooms, one doctor diagnosed Lyme borreliosis an infectious disease transmitted by ticks. With its bite, the parasite introduced bacteria that then spread throughout the entire body. Mrs. S. is not alone very often, the disease is recognized too late or not at all, or is not properly treated. Doctors are provided with no clues if the characteristic redness around the bite area is missing. Left untreated, Lyme borreliosis can cause symptoms that resemble rheumatism, damage joints, muscles and nerves and affect the organs.

If found in time, it can be successfully treated. If patients exhibit the disease-specific rash known as erythema migrans, doctors will prescribe antibiotics for several weeks. However, if, as in the case of Mrs. S., the disease has progressed far and is chronic, it is very difficult to treat. Currently, there is no prophylactic treatment and no vaccine against the infection. In the future, a new type of gel is supposed to nip the infection in the bud: the patient applies it locally immediately after the tick's bite. Researchers of the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig developed the medication in close cooperation with the Swiss company Ixodes AG and the Institute for Infectious Diseases and Zoonoses of the Ludwig-Maximilian University in Munich (Institut fr Infektionsmedizin und Zoonosen der LMU Mnchen). Ixodes AG is responsible for developing the formula, while IZI and LMU are carrying out the pre-clinical studies and the serological examinations.

If the gel is applied immediately to the bite after the tick has been removed and one does not wait for any potential symptoms to show, Lyme borreliosis could be prevented. This is because during the first few days, the bacteria stay right around the spot where the tick bite occurred and spread out only after that. The active ingredient of the gel is azithromycin, which is highly effective against borrelia bacteria and kills them locally in the skin," says Dr. Jens Knauer, project manager at IZI. Unlike other antibiotics, there is no known resistance of borrelia strains against azithromycin. Another advantage of the active ingredient: it has few side effects and as a result does not stress the body. It also distinguishes itself by its good depot action of up to five days in the tissue. The treatment is successful only if the medication is applied within the first few days after the tick's bite. This gel, however, cannot be used to treat an established infection; it is suitable only for prophylaxis," emphasizes Dr. Knauer.

The pre-clinical studies have already been completed successfully; in mice, the gel was effective even five days after a tick's bite. The application has been patented. Starting this past summer, in a clinical phase III study (http://www.zeckenstudie.com), the researchers are testing the medication on persons with proven tick bites. Should the results of the pre-clinical studies be confirmed on humans, the gel will help to significantly lower the number of new infections," the expert adds. Annually, up to 60,000 are stricken with Lyme borreliosis in Germany alone, according to estimates by the Robert Koch Institute, with an upward trend since, due to climate change, ticks are expanding their range ever further. As soon as the gel can be purchased at the pharmacy, persons who are particularly endangered, such as forest rangers, hunters, joggers or soccer players, should always carry it with them," Knauer recommends.


'/>"/>
Contact: Dr. Jens Knauer
jens.knauer@izi.fraunhofer.de
49-341-355-361-206
Fraunhofer-Gesellschaft
Source:Eurekalert

Related biology news :

1. Chinese scientists announce the first complete sequencing of Mongolian genome
2. Worlds first super predator had remarkable vision
3. Max Planck Florida Institute scientists create first realistic 3D reconstruction of a brain circuit
4. Singapore and China scientists perform first Asian genome-wide association study on spine disease
5. Microscopic cells race to victory in first World Cell Race at ASCB meeting
6. Worlds first captive breeding of Ozark hellbenders at Saint Louis Zoo
7. Genetic code of first arachnid cracked
8. Genetic study confirms: First dogs came from East Asia
9. First study to reveal how paracetamol works could lead to less harmful pain relief medicines
10. West coast log, lumber exports in first 9 months of 2011 surpass 2010 totals
11. Paleontologist describes large nest of juvenile dinosaurs, first of their genus ever found
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15 2017   ivWatch LLC , a medical ... (IV) therapy, today announced receipt of its ISO 13485 Certification, the ... the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection ... "This is an important ...
(Date:7/20/2017)... DAL ) customers now can use fingerprints instead of their boarding ... ... biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May at the ... to allow eligible Delta SkyMiles Members who are enrolled in CLEAR to ...
(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... ... Asian exhibitions for analytical and scientific instruments. This year’s symposium, organized by the ... in Mass Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ionization ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum and ... programming through a series of upcoming panels and events. The partnership culminates with the ... Roosevelt Hotel in New York City. , “With our experience in producing the Immuno-Oncology ...
(Date:8/14/2017)... Yorba Linda, Ca (PRWEB) , ... August 14, ... ... allocated for poorly characterized and performing antibodies. Key researchers in the antibody community ... ensure proper characterization and consistency for antibodies in the laboratory. , ...
(Date:8/11/2017)... 2017  Market researcher Kalorama Information was ... regarding the telemedicine market.  The telemedicine market ...  The article, "Heart and Asthma Monitors? ... information from Kalorama Information,s Remote Patient Monitoring ...  (Sleep, Diabetes, Vital Signs /EKG and ...
Breaking Biology Technology: